FAKTOR-OPTIONSSCHEIN - TERADYNE Share Price

Certificat

DE000MA20BK5

Market Closed - Börse Stuttgart 01:23:28 01/06/2024 am IST
0.134 EUR -4.29% Intraday chart for FAKTOR-OPTIONSSCHEIN - TERADYNE
1 month+119.67%
3 months+204.55%
Date Price Change
31/24/31 0.134 -4.29%
30/24/30 0.14 -4.76%
29/24/29 0.147 -8.13%
28/24/28 0.16 +4.58%
27/24/27 0.153 -1.29%

Delayed Quote Börse Stuttgart

Last update May 01, 2024 at 01:23 am IST

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying TERADYNE INC.
Issuer Morgan Stanley
WKN MA20BK
ISINDE000MA20BK5
Date issued 15/09/2020
Strike 113 $
Maturity Unlimited
Parity 187.48 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 175
Lowest since issue 0.024
Spread 0.001
Spread %0.72%

Company Profile

Teradyne, Inc. specializes in the development, manufacturing and marketing of automatic test equipments. Net sales break down by family of products as follows: - semiconductor tester (72.4%); - system testing solutions (13.1%): testers of integrated circuit, digital network cards, electronic modules, military and aerospace instruments, car diagnostic systems, etc.; - industrial automation solutions (9%); - wireless test solutions (5.5%): for mobiles devices and equipments manufacturers (smart phones, tablets, laptops, etc.). Net sales break down by source of income into sales of products (86.2%) and services (13.8%; consulting, development, training and technical support services). Net sales break down geographically as follows: the United States (10.3%), Taiwan (37.8%), China (14.9%), Korea (12.5%), Europe (6.6%), Japan (4.6%), Thailand (4.4%), Singapore (2.4%), Philippines (2.2%), Malaysia (1.8%) and other (2.5%).
Sector
-
More about the company

Ratings for Teradyne Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Teradyne Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
140.9 USD
Average target price
126.3 USD
Spread / Average Target
-10.36%
Consensus